Shield AI, the San Diego-based defence technology company, has raised $2 billion in new funding at a valuation of $12.7 billion, more than doubling its worth from a year ago. The round was co-led by Advent International and JPMorgan's Strategic Investment Group, with Blackstone contributing an additional $500 million in preferred equity. The company's Hivemind autonomy software was recently selected for the US Air Force's Collaborative Combat Aircraft programme, a drone project that will see autonomous wingmen flying alongside crewed fighters. That contract, more than anything else, explains why the numbers are this large.
The trajectory is striking even by the standards of the current AI funding environment. Shield AI was valued at $5.3 billion in March 2025. Twelve months later it has more than doubled. For context, that $12.7 billion figure puts it ahead of most regional airlines, several large hospital groups, and any number of traditional defence contractors that have been operating for decades. What Shield AI actually sells is software: Hivemind is an autonomy stack that allows drones and other aircraft to fly missions without GPS, communications links, or human operators in the loop. The pitch to the military is resilience in contested environments where adversaries will try to jam everything.
The backdrop to this funding round is the broader US defence posture under the current administration. Defence budgets are rising, there is explicit political pressure to favour American technology providers, and the US military has been very publicly exploring how AI can reduce the cost of fielding effective combat systems. The Collaborative Combat Aircraft programme, in which Shield AI is now a designated provider, is a direct expression of that: smaller, cheaper autonomous aircraft that can be produced in volume and expended in ways that crewed jets cannot. At $12.7 billion, investors are betting that Hivemind becomes the default operating system for that category of weapon.
Bloomberg and TechCrunch frame the story slightly differently. Bloomberg emphasises the investment syndicate and the clean doubling of valuation as a signal about the defence tech sector broadly. TechCrunch focuses on the Air Force deal as the specific catalyst, noting that the company's growth has tracked its progress through the military procurement process. Both readings are correct: the valuation reflects both a genuine product milestone and a surge of capital looking for exposure to the defence AI theme.
There are real questions here that the funding announcement does not resolve. Military AI autonomy operates in a regulatory and ethical space that is genuinely contested. The question of how much decision-making authority to give an autonomous weapon system is not settled policy in any major military, and the legal frameworks governing autonomous lethal systems remain incomplete. Shield AI's CEO has been explicit that the company is "focused on helping militaries succeed on the battlefield," which is a coherent commercial position but not a position that addresses the harder questions about accountability when autonomous systems cause civilian harm.
For the AI industry more broadly, the Shield AI round is a reminder that defence remains a large and fast-growing market that the major AI labs have mostly been reluctant to pursue directly. That reluctance has created space for specialist players. Whether those players eventually get acquired by larger defence primes, go public, or continue as independents will shape how military AI capability is distributed and governed over the next decade. At $12.7 billion and growing, Shield AI is no longer a startup making a speculative bet on the future of warfare. It is now a substantive player in a conversation with significant consequences.